POLATUZUMAB VEDOTIN
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | POLATUZUMAB VEDOTIN |
| DrugBank ID | DB12240 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 65 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| coccidioidomycosis | TxGNN Knowledge Graph | L5 |
| oral candidiasis | TxGNN Knowledge Graph | L5 |
| gingivitis | TxGNN Knowledge Graph | L5 |
| bronchitis | TxGNN Knowledge Graph | L5 |
| candidemia | TxGNN Knowledge Graph | L5 |
| mycotic corneal ulcer | TxGNN Knowledge Graph | L5 |
| necrotizing ulcerative gingivitis | TxGNN Knowledge Graph | L5 |
| staphylococcus aureus infection | TxGNN Knowledge Graph | L5 |
| aids | TxGNN Knowledge Graph | L5 |
| streptococcal infection | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11